glp-1 pancreatic cancer Risk: What New Data Reveal Ozempic and Cancer Risk: Study

**COMMENT "REGULATORY" or SEND US A DM for an expert answer.** Let us help you navigate the risk

Am J Physiol Regul Integr Comp Physiol (2013) 305(1):R6877

Pradhan, R., Yu, O

The lack of clarity makes choosing a company potentially confusing for patients, and the medical profession is partly to blame, said Jamy Ard, an obesity doctor and researcher at Wake Forest University School of Medicine in Winston-Salem, North Carolina

Preclinical studies in rodent models have consistently demonstrated that GLP-1 agonists decrease alcohol consumption, reduce alcohol-seeking behavior, and prevent relapse-like drinking after periods of abstinence

Because these hormonal pathways can be tied to numerous bodily processes, researchers are now trying to study what else GLP-1 analogs could potentially treat